Characterisation and prevention of "Stunning", a cytotoxic T lymphocyte inactivating program that impairs adoptive cell therapy against cancer

Lead researcher

Prof Jose Villadangos, Prof William Heath

Institution

The University of Melbourne; Microbiology and Immunology

Years funded

2016-2018

This project seeks to identify the factors that turn off therapeutic cancer-killing immune cells in patients. The results will help us prepare more effective treatments using live anti-cancer cell therapies.

Funding Body

Cancer Council Research Grant

Funding

$100,000 pa for three years

Updated: